Evidence map›Paper›PMID 37189145›Full record

ArticleBMC public health2023

Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California.

Beth Waitzfelder, Latha Palaniappan, Alexandra Varga, Timothy B Frankland, Jiang Li, Yihe G Daida, Joseph Keawe'aimoku Kaholokula, Adrian Matias Bacong, Andreea M Rawlings, Sukyung Chung and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06471595 (Peau o le Vasa), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06471595 nacompletednot on this mapstarted 2024, after this paper: background citation

Peau o le Vasa: Accelerating the Currents of Health Equity for Pasifika People

TypeinterventionalSponsorUniversity of HawaiiRan2024 to 2025Enrolled242ConditionsWeight Loss Trial, Cardiometabolic Syndrome, Hypertension, DyslipidemiaArmsPartnership for Improving Lifestyle Intervention (PILI) Lifestyle Program + Social Determinants of Health (SDOH) Component
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Beth WaitzfelderCenter for Integrated Health Care Research, Kaiser Permanente Hawai'i, Honolulu, HI, USA.
Latha PalaniappanStanford University School of Medicine, Stanford, CA, USA.
Alexandra VargaKaiser Permanente Center for Health Research, 3800 N. Interstate Ave., Portland, OR, 97227, USA.
Timothy B FranklandCenter for Integrated Health Care Research, Kaiser Permanente Hawai'i, Honolulu, HI, USA.
Jiang LiPalo Alto Medical Foundation Research Institute, Center for Health Systems Research, Sutter Health, Palo Alto, CA, USA.
Yihe G DaidaCenter for Integrated Health Care Research, Kaiser Permanente Hawai'i, Honolulu, HI, USA.
Joseph Keawe'aimoku KaholokulaDepartment of Native Hawaiian Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, USA.
Adrian Matias BacongStanford University School of Medicine, Stanford, CA, USA.
Andreea M RawlingsKaiser Permanente Center for Health Research, 3800 N. Interstate Ave., Portland, OR, 97227, USA.
Sukyung ChungGenesis Research, Hoboken, NJ, USA.
Connor HowickCenter for Integrated Health Care Research, Kaiser Permanente Hawai'i, Honolulu, HI, USA.
Stephen P FortmannKaiser Permanente Center for Health Research, 3800 N. Interstate Ave., Portland, OR, 97227, USA. stephen.p.fortmann@kpchr.org.
Kaiser Permanente · USKaiser Permanente Center for Health Research · USStanford University · USSutter Health · USUniversity of Hawaiʻi at Mānoa · US

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Tracking and Evaluation CoreU54GM138062 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI SHIKUMA, CECILIA M. · 2021 to 2025
$15.5M
Cardiovascular Disease Among Asians and Pacific Islanders (CASPER)R01HL126172 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI FORTMANN, STEPHEN PAUL, PALANIAPPAN, LATHA P · 2015 to 2018
$3.0M
META - Mentor, Educate, Train, Advocate: Patient Oriented Researchers in Cardiometabolic DiseaseK24HL150476 · NHLBI · STANFORD UNIVERSITY · PI Latha P Palaniappan · 2020 to 2026
$846k
NCATS NIH HHS UL1 TR003142NHLBI NIH HHS K24 HL150476NHLBI NIH HHS R01 HL126172NIGMS NIH HHS U54 GM138062
6 · The paper itself

Abstract

backgroundCardiovascular disease (CVD) remains the leading cause of death in the US. CVD incidence is influenced by many demographic, clinical, cultural, and psychosocial factors, including race and ethnicity. Despite recent research, there remain limitations on understanding CVD health among Asians and Pacific Islanders (APIs), particularly some subgroups and multi-racial populations. Combining diverse API populations into one study group and difficulties in defining API subpopulations and multi-race individuals have hampered efforts to identify and address health disparities in these growing populations.

methodsThe study cohort was comprised of all adult patients at Kaiser Permanente Hawai'i and Palo Alto Medical Foundation in California during 2014-2018 (n = 684,363). EHR-recorded ICD-9 and ICD-10 diagnosis codes were used to indicate coronary heart disease (CHD), stroke, peripheral vascular disease (PVD), and overall CVD. Self-reported race and ethnicity data were used to construct 12 mutually exclusive single and multi-race groups, and a Non-Hispanic White (NHW) comparison group. Logistic regression models were used to derive prevalence estimates, odds ratios, and confidence intervals for the 12 race/ethnicity groups.

resultsThe prevalence of CHD and PVD varied 4-fold and stroke and overall CVD prevalence varied 3-fold across API subpopulations. Among Asians, the Filipino subgroup had the highest prevalence of all three CVD conditions and overall CVD. Chinese people had the lowest prevalence of CHD, PVD and overall CVD. In comparison to Native Hawaiians, Other Pacific Islanders had significantly higher prevalence of CHD. For the multi-race groups that included Native Hawaiians and Other Pacific Islanders, the prevalence of overall CVD was significantly higher than that for either single-race Native Hawaiians or Other Pacific Islanders. The multi-race Asian + White group had significantly higher overall CVD prevalence than both the NHW group and the highest Asian subgroup (Filipinos).

conclusionsStudy findings revealed significant differences in overall CVD, CHD, stroke, and PVD among API subgroups. In addition to elevated risk among Filipino, Native Hawaiian, and Other Pacific Islander groups, the study identified particularly elevated risk among multi-race API groups. Differences in disease prevalence are likely mirrored in other cardiometabolic conditions, supporting the need to disaggregate API subgroups in health research.

Indexed as

Asian American Native Hawaiian and Pacific IslanderCardiovascular DiseasesAdultCaliforniaHawaiiHumansPrevalenceAsianCardiovascular diseaseFilipinoNative HawaiianPacific IslanderStroke

Identifiers

PMID37189145
PMCPMC10184427
OpenAlexW4376610665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.